openPR Logo
Press release

Peripheral Artery Revascularization Market to be at Forefront by 2018 – 2028

08-06-2019 01:07 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Peripheral Artery Revascularization Market to be at Forefront

Peripheral artery disease (PAD) is a blood circulation disorder due to buildup of plaque in the arteries that supply blood to the peripheral organs such as legs, arms, and others organs apart from brain and heart. Patients with PAD are at the higher risk for major atherothrombotic events such as stroke and myocardial infarction. Peripheral artery revascularization is minimally invasive treatment to improve blood circulation with less pain and scarring, and faster recovery time. Increasing prevalence of lifestyle diseases such as obesity and diabetes associated with high cholesterol level has led to peripheral artery disease which in turn influences the development of peripheral artery revascularization market.

The peripheral artery revascularization market is expected to witness a steady growth in the coming years with rising number of geriatric population across the globe. More instances of smoking, high blood pressure, and high cholesterol level on the coattails of unhealthy lifestyle habits are likely drive the peripheral artery revascularization market. Government initiatives in the development of healthcare sector along with growing awareness of new treatment methods are the major factors fuelling peripheral artery revascularization market. Adoption of innovative vascularization techniques and new technologies will possibly create potential growth prospects of peripheral artery revascularization market.

Request to Sample report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1004

Peripheral arteries are blood vessels which carry blood from heart to arms and legs or organs apart from brain and heart. Peripheral artery disease is most common form of peripheral vessels disease. Peripheral artery revascularization is required when blood is not supplied efficiently to peripheral organs. Peripheral arteries often get blocked to plaque formation (formed of extra cholesterol, calcium and other materials) or narrowing of peripheral arteries. Peripheral artery revascularization is one of the effective way to restore blood flow to peripheral organs. Changing lifestyle, high cholesterol, high blood pressure and smoking leads to plaque clog buildup in peripheral arteries adversely affecting blood flow to distant organs. Claudication, critical limb ischemia, and acute limb ischemia are three major conditions in which peripheral artery revascularization is done. Peripheral artery revascularization is more common in critical limb ischemia and acute limb ischemia.

Peripheral Artery Revascularization Market: Drivers and Restraints

Increasing worldwide prevalence of peripheral artery disease is attributed to significant growth of peripheral artery revascularization market. More than 10% of U.S. citizens over the age of 65 years have peripheral artery disease leading to increasing peripheral artery revascularization market. Peripheral artery disease prevalence is further on the rise due to increasing prevalence of risk factors such as diabetes, obesity, hypertension and use of tobacco driving peripheral artery revascularization market. Increasing obesity and tobacco use are the major driving factors of peripheral artery revascularization market. World’s aging population is expected to increase in coming years, increasing peripheral artery disease cases and attributing to peripheral artery revascularization market growth. More than 200 million people worldwide have peripheral artery disease which in turn is driving the peripheral artery revascularization market. Peripheral artery revascularization market is further expected to grow due to increasing procedures in developing countries. Higher cost of procedure appears to be the only restraint in peripheral artery revascularization market growth.

Peripheral Artery Revascularization Market: Segmentation

Tentatively, the global peripheral artery revascularization market can be segmented on the basis of product type, procedure type, indication type, end use, and geography.

Based on Product type, the global peripheral artery revascularization market is segmented as:

Stents
Grafts
Percutaneous trans-luminal angioplasty (PTA) balloons
PTA drug-eluting balloons
Based on Procedure type, the global peripheral artery revascularization market is segmented as:

Vascular bypass
Angioplasty
Based on Indication type, the global peripheral artery revascularization market is segmented as:

Lower Extremity Revascularization
Renal Arterial Revascularization
Mesenteric Arterial Revascularization
Abdominal Aortic Revascularization
Based on end user, the global peripheral artery revascularization market is segmented as

Hospitals
Ambulatory surgical centers
Specialized clinics
Peripheral artery revascularization Market: Overview

Global peripheral artery revascularization market is expected to grow significantly over the forecast period attributing to increasing prevalence of peripheral artery disease. Increasing global geriatric population is expected to contribute significantly to peripheral artery revascularization market growth. Worldwide prevalence of peripheral artery disease is around 200 million, driving peripheral artery revascularization market growth. New technologies like stent are expected to dominate product type segment of peripheral artery revascularization market. By indication type, lower extremity revascularization is the most dominating segment of peripheral artery revascularization market attributing to high prevalence. By end user type, hospitals are the dominating segment due to wide range of acceptance and convenience. Peripheral artery revascularization market is witnessing innovative techniques of vascularization along with mergers and acquisitions.

Peripheral artery revascularization Market: Regional Outlook

Approximately, more than 10% people with peripheral artery disease live in the U.S. Nearly, 70% of total population affected with peripheral artery disease live in low to middle income regions. Hence, Asia-Pacific and Middle East peripheral artery revascularization market is expected to grow significantly. Regions like North America and Europe are witnessing steady growth in prevalence of peripheral artery disease which in turn leads to growth of the peripheral artery revascularization market.

Request For Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=1004

Peripheral artery revascularization Market: Key Players

Some of the global key players operating in peripheral artery revascularization market are Boston Scientific Corporation, Abbott Laboratories, AngioDynamics, Inc., Cook Medical, Cardinal Health, Inc., C. R. Bard, Inc., The Spectranetics Corporation, Medtronic plc, Terumo Corporation.

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peripheral Artery Revascularization Market to be at Forefront by 2018 – 2028 here

News-ID: 1818659 • Views:

More Releases from Fact.MR

Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2034 | Key players: Pfizer Inc., F. Hoffman-La Roche Ltd., Sanofi S.A., and Seattle Genetics, and Genentech.
10-03-2025 | Health & Medicine
Fact.MR
Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 …
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent need
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, Led by Roche, Boehringer Ingelheim & Others
10-03-2025 | Health & Medicine
Fact.MR
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L …
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements in
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | McCormick & Company, Associated British Foods, Olam International, Sensient Technologies, Kerry Group
10-03-2025 | Food & Beverage
Fact.MR
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc …
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by rising
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% CAGR, Supported by PwC, EY, Deloitte & KPMG
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% …
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035. The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourced

All 5 Releases


More Releases for Peripheral

Peripheral Vascular Devices Market - Advancing vascular health: Cutting-edge dev …
Newark, New Castle, USA: The "Peripheral Vascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Peripheral Vascular Devices Market: https://www.growthplusreports.com/report/peripheral-vascular-devices-market/7820 This latest report researches the industry structure,
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele …
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview of
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533 The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a